Literature DB >> 20718749

Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery.

K M Mair1, E Robinson, K A Kane, S Pyne, R R Brett, N J Pyne, S Kennedy.   

Abstract

BACKGROUND AND
PURPOSE: Anandamide and sphingosine-1-phosphate (S1P) both regulate vascular tone in a variety of vessels. This study aimed to examine the mechanisms involved in the regulation of coronary vascular tone by anandamide and S1P, and to determine whether any functional interaction occurs between these receptor systems. EXPERIMENTAL APPROACH: Mechanisms used by anandamide and S1P to regulate rat coronary artery (CA) reactivity were investigated using wire myography. Interactions between S1P and the cannabinoid (CB)(2) receptor were determined using human embryonic kidney 293 (HEK293) cells that stably over-express recombinant CB(2) receptor. KEY
RESULTS: Anandamide and S1P induced relaxation of the rat CA. CB(2) receptor antagonists attenuated anandamide-induced relaxation, while S1P-mediated relaxation was dependent on the vascular endothelium and S1P(3). Anandamide treatment resulted in an increase in the phosphorylation of sphingosine kinase-1 within the CA. Conversely, anandamide-mediated relaxation was attenuated by inhibition of sphingosine kinase. Moreover, S1P(3), specifically within the vascular endothelium, was required for anandamide-mediated vasorelaxation. In addition to this, S1P-mediated relaxation was also reduced by CB(2) receptor antagonists and sphingosine kinase inhibition. Further evidence that S1P functionally interacts with the CB(2) receptor was also observed in HEK293 cells over-expressing the CB(2) receptor. CONCLUSIONS AND IMPLICATIONS: In the vascular endothelium of rat CA, anandamide induces relaxation via a mechanism requiring sphingosine kinase-1 and S1P/S1P(3). In addition, we report that S1P may exert some of its effects via a CB(2) receptor- and sphingosine kinase-dependent mechanism, where subsequently formed S1P may have privileged access to S1P(3) to induce vascular relaxation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20718749      PMCID: PMC2962826          DOI: 10.1111/j.1476-5381.2010.00878.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells.

Authors:  J Igarashi; S G Bernier; T Michel
Journal:  J Biol Chem       Date:  2001-01-17       Impact factor: 5.157

2.  Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.

Authors:  I Galve-Roperh; C Sánchez; M L Cortés; T Gómez del Pulgar; M Izquierdo; M Guzmán
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

3.  Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.

Authors:  J Grainger; G Boachie-Ansah
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme.

Authors:  C Blázquez; C Sánchez; A Daza; I Galve-Roperh; M Guzmán
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Authors:  Z Járai; J A Wagner; K Varga; K D Lake; D R Compton; B R Martin; A M Zimmer; T I Bonner; N E Buckley; E Mezey; R K Razdan; A Zimmer; G Kunos
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

6.  Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation.

Authors:  Nicolas Ancellin; Chantal Colmont; Joseph Su; Qin Li; Nanette Mittereder; Sung-Suk Chae; Steingrimur Stefansson; Gene Liau; Timothy Hla
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

7.  Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.

Authors:  P M Zygmunt; J Petersson; D A Andersson; H Chuang; M Sørgård; V Di Marzo; D Julius; E D Högestätt
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

8.  Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction.

Authors:  J Igarashi; T Michel
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

9.  The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1).

Authors:  D Smart; M J Gunthorpe; J C Jerman; S Nasir; J Gray; A I Muir; J K Chambers; A D Randall; J B Davis
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

10.  Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries.

Authors:  R White; W S Ho; F E Bottrill; W R Ford; C R Hiley
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

View more
  14 in total

1.  Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P-Selectin Activity.

Authors:  Virginie Esain; Wanda Kwan; Kelli J Carroll; Mauricio Cortes; Sarah Y Liu; Gregory M Frechette; Lea M V Sheward; Sahar Nissim; Wolfram Goessling; Trista E North
Journal:  Stem Cells       Date:  2015-05-26       Impact factor: 6.277

Review 2.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

3.  Production and actions of the anandamide metabolite prostamide E2 in the renal medulla.

Authors:  Joseph K Ritter; Cao Li; Min Xia; Justin L Poklis; Aron H Lichtman; Rehab A Abdullah; William L Dewey; Pin-Lan Li
Journal:  J Pharmacol Exp Ther       Date:  2012-06-08       Impact factor: 4.030

Review 4.  Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system.

Authors:  Mirjam Schuchardt; Markus Tölle; Jasmin Prüfer; Markus van der Giet
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

5.  Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology?

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Front Pharmacol       Date:  2011-05-31       Impact factor: 5.810

6.  Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects.

Authors:  Salvatore Salomone; Christian Waeber
Journal:  Front Pharmacol       Date:  2011-02-22       Impact factor: 5.810

7.  High density lipoprotein stimulated migration of macrophages depends on the scavenger receptor class B, type I, PDZK1 and Akt1 and is blocked by sphingosine 1 phosphate receptor antagonists.

Authors:  Aishah Al-Jarallah; Xing Chen; Leticia González; Bernardo L Trigatti
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

8.  Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.

Authors:  Chao Li; Jun-nan Li; Joanne Kays; Miguel Guerrero; Grant D Nicol
Journal:  J Neuroinflammation       Date:  2015-04-12       Impact factor: 8.322

9.  The effect of sphingosine-1-phosphate on colonic smooth muscle contractility: Modulation by TNBS-induced colitis.

Authors:  Aishah Al-Jarallah; Mabayoje Oriowo
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

Review 10.  Vascular targets for cannabinoids: animal and human studies.

Authors:  Christopher Stanley; Saoirse E O'Sullivan
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.